The fate of mitochondria during platelet activation.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
24 Oct 2023
Historique:
accepted: 08 08 2023
received: 07 04 2023
pubmed: 25 8 2023
medline: 25 8 2023
entrez: 25 8 2023
Statut: ppublish

Résumé

Blood platelets undergo several successive motor-driven reorganizations of the cytoskeleton when they are recruited to an injured part of a vessel. These reorganizations take place during the platelet activation phase, the spreading process on the injured vessel or between fibrin fibers of the forming clot, and during clot retraction. All these steps require a lot of energy, especially the retraction of the clot when platelets develop strong forces similar to those of muscle cells. Platelets can produce energy through glycolysis and mitochondrial respiration. However, although resting platelets have only 5 to 8 individual mitochondria, they produce adenosine triphosphate predominantly via oxidative phosphorylation. Activated, spread platelets show an increase in size compared with resting platelets, and the question arises as to where the few mitochondria are located in these larger platelets. Using expansion microscopy, we show that the number of mitochondria per platelet is increased in spread platelets. Live imaging and focused ion beam-scanning electron microscopy suggest that a mitochondrial fission event takes place during platelet activation. Fission is Drp1 dependent because Drp1-deficient platelets have fused mitochondria. In nucleated cells, mitochondrial fission is associated with a shift to a glycolytic phenotype, and using clot retraction assays, we show that platelets have a more glycolytic energy production during clot retraction and that Drp1-deficient platelets show a defect in clot retraction.

Identifiants

pubmed: 37624769
pii: 497598
doi: 10.1182/bloodadvances.2023010423
pmc: PMC10589785
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6290-6302

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL144957
Pays : United States

Informations de copyright

© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Références

Redox Biol. 2014 Jan 10;2:206-10
pubmed: 24494194
Cells. 2021 Mar 06;10(3):
pubmed: 33800866
Dev Cell. 2017 Mar 27;40(6):583-594.e6
pubmed: 28350990
Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):481-8
pubmed: 23288151
Front Cardiovasc Med. 2019 Oct 29;6:153
pubmed: 31737646
Biochim Biophys Acta. 1969 Feb 25;172(2):266-76
pubmed: 5775696
Nat Commun. 2017 Nov 2;8(1):1274
pubmed: 29097692
Haematologica. 2022 May 01;107(5):1209-1213
pubmed: 34937318
Biochem Soc Trans. 2013 Feb 1;41(1):118-23
pubmed: 23356269
PLoS One. 2015 Apr 13;10(4):e0123597
pubmed: 25875958
Curr Opin Cell Biol. 2023 Feb;80:102150
pubmed: 36580830
Blood. 2016 Nov 24;128(21):2538-2549
pubmed: 27625359
Dev Cell. 2008 Feb;14(2):193-204
pubmed: 18267088
J Cell Sci. 2014 Nov 1;127(Pt 21):4549-60
pubmed: 25217628
J Biol Chem. 2019 Mar 8;294(10):3385-3396
pubmed: 30602572
iScience. 2021 Dec 27;25(1):103690
pubmed: 35059605
Blood. 2008 May 1;111(9):4605-16
pubmed: 18230754
Blood. 1989 Nov 1;74(6):1983-8
pubmed: 2804343
Thromb Res. 2020 Dec;196:175-185
pubmed: 32890901
Prog Biophys Mol Biol. 2019 Jul;144:166-176
pubmed: 29843920
Nat Methods. 2019 Jan;16(1):71-74
pubmed: 30559430
Blood. 2014 Oct 2;124(14):2173-83
pubmed: 25082876
Blood Rev. 2011 Jul;25(4):155-67
pubmed: 21496978
Blood. 1967 Sep;30(3):321-30
pubmed: 6038304
J Thromb Haemost. 2015 Mar;13(3):333-46
pubmed: 25510620
Nat Mater. 2011 Jan;10(1):61-6
pubmed: 21131961
Nat Cell Biol. 2019 May;21(5):603-613
pubmed: 30988424
Elife. 2017 Nov 09;6:
pubmed: 29119945
Sci Rep. 2018 Apr 3;8(1):5428
pubmed: 29615672
Methods Cell Biol. 2021;161:57-81
pubmed: 33478697
Cell. 2016 Jun 30;166(1):63-76
pubmed: 27293185
Biochim Biophys Acta. 2012 Oct;1817(10):1833-8
pubmed: 22409868
Haematologica. 2019 Apr;104(4):806-818
pubmed: 30381300
J Cell Biol. 2014 Jan 20;204(2):177-85
pubmed: 24421335
Pharmacol Res Perspect. 2016 Apr 21;4(3):e00235
pubmed: 27433345
J Thromb Haemost. 2018 Nov;16(11):2300-2314
pubmed: 30151891
Lab Invest. 2013 Jun;93(6):690-700
pubmed: 23528848
Res Pract Thromb Haemost. 2019 Oct 25;4(1):72-85
pubmed: 31989087
Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14266-71
pubmed: 26578771
J Thromb Haemost. 2008 Nov;6(11):1944-52
pubmed: 18761725
Sci Rep. 2021 May 18;11(1):10511
pubmed: 34006947
Nature. 2021 Feb;590(7844):57-66
pubmed: 33536648

Auteurs

Alexei Grichine (A)

INSERM U1209, Centre National de la Recherche Scientifique Unité Mixed de Recherche 5309, Institute for Advanced Biosciences, University Grenoble Alpes, Grenoble, France.

Shancy Jacob (S)

Molecular Medicine Program, University of Utah, Salt Lake City, UT.

Anita Eckly (A)

INSERM, EFS Grand Est, Biologie et Pharmacologie des Plaquettes Sanguines Unité Mixed de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, University of Strasbourg, Strasbourg, France.

Joran Villaret (J)

INSERM U1209, Centre National de la Recherche Scientifique Unité Mixed de Recherche 5309, Institute for Advanced Biosciences, University Grenoble Alpes, Grenoble, France.

Clotilde Joubert (C)

INSERM U1209, Centre National de la Recherche Scientifique Unité Mixed de Recherche 5309, Institute for Advanced Biosciences, University Grenoble Alpes, Grenoble, France.

Florence Appaix (F)

INSERM U1209, Centre National de la Recherche Scientifique Unité Mixed de Recherche 5309, Institute for Advanced Biosciences, University Grenoble Alpes, Grenoble, France.

Mylène Pezet (M)

INSERM U1209, Centre National de la Recherche Scientifique Unité Mixed de Recherche 5309, Institute for Advanced Biosciences, University Grenoble Alpes, Grenoble, France.

Anne-Sophie Ribba (AS)

INSERM U1209, Centre National de la Recherche Scientifique Unité Mixed de Recherche 5309, Institute for Advanced Biosciences, University Grenoble Alpes, Grenoble, France.

Eric Denarier (E)

INSERM U1216, Commissariat à l'Energie Atomique, Grenoble Institute of Neuroscience, University Grenoble Alpes, Grenoble, France.

Jacques Mazzega (J)

INSERM U1209, Centre National de la Recherche Scientifique Unité Mixed de Recherche 5309, Institute for Advanced Biosciences, University Grenoble Alpes, Grenoble, France.

Jean-Yves Rinckel (JY)

INSERM, EFS Grand Est, Biologie et Pharmacologie des Plaquettes Sanguines Unité Mixed de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, University of Strasbourg, Strasbourg, France.

Laurence Lafanechère (L)

INSERM U1209, Centre National de la Recherche Scientifique Unité Mixed de Recherche 5309, Institute for Advanced Biosciences, University Grenoble Alpes, Grenoble, France.

Bénédicte Elena-Herrmann (B)

INSERM U1209, Centre National de la Recherche Scientifique Unité Mixed de Recherche 5309, Institute for Advanced Biosciences, University Grenoble Alpes, Grenoble, France.

Jesse W Rowley (JW)

Molecular Medicine Program, University of Utah, Salt Lake City, UT.

Karin Sadoul (K)

INSERM U1209, Centre National de la Recherche Scientifique Unité Mixed de Recherche 5309, Institute for Advanced Biosciences, University Grenoble Alpes, Grenoble, France.

Classifications MeSH